SYBX
Synlogic IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$7.78M
P/E Ratio
—
EPS
$-0.06
Beta
0.52
52W High
$1.96
52W Low
$0.54
50-Day MA
$0.64
200-Day MA
$1.10
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Synlogic Inc
Synlogic, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of synthetic biotic drugs to treat cancer, inflammatory, and metabolic diseases in the United States. The company is headquartered in Cambridge, Massachusetts.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-3.19M |
| Operating Margin | 0.00% |
| Return on Equity | -8.17% |
| Return on Assets | -12.50% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $1.01 |
| Price-to-Book | 0.61 |
| Price-to-Sales (TTM) | 936.86 |
| EV/Revenue | 0.349 |
| EV/EBITDA | 0.18 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -100.00% |
| Shares Outstanding | $11.70M |
| Float | $3.48M |
| % Insiders | 22.60% |
| % Institutions | 35.28% |
Historical Volatility
HV 10-Day
12.18%
HV 20-Day
34.11%
HV 30-Day
28.37%
HV 60-Day
49.49%
HV Rank
—
Volatility is currently contracting
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on SYBX and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 5/29/2026